The FluFIT Program: Leveraging Flu Shot Campaigns to Promote Colorectal Cancer Screening October 11, 2013

Background  American Cancer Society and Telligen seized opportunity to collaborate on common objective  Reviewed Dr. Potter’s research  Explored the question - Could we implement a similar project in Iowa? 2

Identifying Focus Areas  Planning initiated through  Data review  Colorectal Cancer Smooth Maps  Other sources  Potential clinics identified 3

Clinic Recruitment  Decided FQHC would be ideal  Provide primary care preventive services  Reaching disparate/underserved populations  Worked through Iowa Primary Care Association  Selected Primary Health Care in Marshalltown and clinic agreed  NCQA Level 3 PCMH 4

Intake Meeting Clinic leadership, ACS, Telligen  Reviewed required components of FluFIT pilot  Learned about clinic operations  Shared FluFIT resources and tools  Discussed applying for ICC grant  Set a goal to increase CRC screening by 48% 5

Planning  Received ICC funding  Identified pilot project period; end of September 2013 through March 2014  Prepared Action Plan Activities Checklist  Recognized many processes already in place, therefore, minimal impact on staff  Noted EHR had many capabilities to utilize  Customized materials for PHC 6

7

Training  Materials – PPT presentation handouts and resource book  Approach - Train the Trainer  First training – August 29  Training Participants – Nursing staff and lead front staff  Feedback was positive  Refresher training - Held mid-September 8

Data Collection and Reporting  Number vaccinations given to eligible patients  Number offered & accepted FIT kits  Number of patient reminders  Number of kits returned  Percentage positive/negative  Number of patients requiring additional follow-up 9

10

Remarks by PHC Marshalltown Clinic Director 11

Plans for the Future  Continue at same clinic  Replicate in other clinics  Explore pharmacy pilot 12

ACS National FluFIT Pilot Project  5 pilot sites across the nations selected  PHC is one of the pilot sites  Data collection September – December 2013  ACS evaluator will work with the pilots  Anticipated outcome is replication 13

Contacts  Lorrie Graaf, American Cancer Society   Frann Otte, Telligen  14

Questions 15